Aeglea BioTherapeutics, Inc. 4
4 · Aeglea BioTherapeutics, Inc. · Filed Mar 22, 2017
Insider Transaction Report
Form 4
Lowe David George
DirectorCEO and President
Transactions
- Award
Employee Stock Option (right to buy)
2017-03-20+160,000→ 160,000 totalExercise: $8.03Exp: 2027-03-19→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on April 20, 2017, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.